semaglutide being pulled from market Compounding pharmacies to halt sales May 22 US Market For Obesity Drugs

Prices for semaglutide the brand name for buzzy prescription injections such as Ozempic and Wegovy are far higher in the US than they are in the UK and more than a dozen countries across the globe, according to a recent study published in the journal Obesity

Taking less than prescribed doses means you wont achieve the full benefits the medication offers

A status report from both parties is expected by November 21

Current diabetes guidelines recommend multifactorial CV risk management and the preferential use of a glucagon-like peptide-1 receptor agonist (GLP-1RA) or sodiumglucose cotransporter-2 inhibitor with proven CV benefits as a first choice add-on to metformin in patients with T2D and established atherosclerotic CVD [2, 4]